BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 23, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Oct. 22, 2024

View Archived Issues
PRIMA implant

Science Corp.’s Prima enables blind patients to read

Preliminary results from a trial demonstrated that Science Corp.’s Prima retina implant restored ‘form vision,’ including the ability to read in patients with vision loss. Originally developed at Stanford University and then advanced by Pixium Vision SA, Prima received U.S. FDA breakthrough device designation in April 2023. Read More

UK MHRA posts series of stringent regulatory requirements

The U.K.'s Medicines and Health Care Products Regulatory Agency posted a series of draft new regulations that will increase the requirements for device makers doing business in the U.K. Read More
Baxter logo

Baxter North Carolina facility recovering from Hurricane Helene

Baxter International Inc., whose North Cove manufacturing site in Marion, North Carolina, was significantly impacted by the rain and storm surge from Hurricane Helene – including flooding of the facility – in September, reported that restoring the physical facilities has exceeded its expectations, with meaningful advances in site cleanup and remediation. Read More
Michelle Tarver, FDA device center director

FDA confirms Tarver taking over at agency’s device center

The U.S. FDA declared that Michelle Tarver is the permanent replacement for Jeff Shuren as the director of the agency’s device center. The news is hardly a surprise as Shuren confirmed the appointment in an October 2024 public meeting. Read More
europe-uk-flag-map.png

NICE sees need for more evidence for tests for ADHD

The U.K. National Institute for Health and Care Excellence endorsed the Qb Test by Qbtech AB of Stockholm to aid in diagnosis of attention deficit/hyperactivity disorder in those aged 6 to 17. Read More
DNA analysis illustration

Mapping and categorizing cancer drug resistance mechanisms

Starting with a study of how mutations affect sensitivity to 10 molecularly targeted drugs, researchers have laid the foundations for a prospective, systematic approach to understanding the genetic mechanisms behind cancer drug resistance. Read More

Appointments and advancements for October 22, 2024

New hires and promotions in the med-tech industry, including: Accuray, Axxess, Catalyst Orthoscience, Gradient Denervation Technologies, Grail, Know Labs. Read More

Financings for October 22, 2024

Med-tech firms raising money in public or private financings, including: Bioaffinity Technologies, Okami Medical. Read More

In the clinic for October 22, 2024

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Doctorpresso, Extend Fertility. Read More

Other news to note for October 22, 2024

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3X4 Genetics, Access Genetics, Autonomix, Bioinformatics Solutions, Capsulomics, Danaher, Digital Health Navigation, Echolight, Envoy, Gradient Denervation Technologies, Healthlynked, Lin Health, LISA, Mayo Clinic, Mpath Health, Neuraxis, Novastep, Osteotec, Oraldna Labs, Previse Dx, Sciex, Sensible Diagnostics, Twist. Read More

Regulatory actions for October 22, 2024

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Eptiel, Irhythm, Peytant. Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 17, 2026
  • SERCA inhibitor from Sumitomo shows promise for MSA-C treatment

    BioWorld Science
    At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing